To support various types of target validation, ICE now is expanding cell bank including commercial cell lines from ATCC, Cobioer, Invivogen and JCRB, resistant cell lines generated by CRISPR system and continuous drug selection, transcription reporter cell lines, HiBiT-based protein degradation cell lines, protein overexpressed cell lines like GPCR and ion Channel cells lines etc.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel：+86-10-67809840
